Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta‐analysis by Beverly, A, Ong, G, Kimber, C, Sandercock, J, Dorée, C, Welton, NJ, Wicks, P, Estcourt, LJ

“…All of the trials were funded by pharmaceutical companies.<br> None of the five trials reported the number of red cells transfused per participant up to 30 days or the number of participants requiring an allogeneic blood transfusion up to 30 days.…”

A New Frontier in the Fight Against Cancer (That Is, for Those Who Can Afford It) by Jennifer Gumer

“…Also, insurers are discussing ways to devise alternative payment models for gene therapies such as paying for a treatment over time, the establishment of insurer risk pools, and the potential financing of one time payments.[6] How all this will play out remains to be seen, but pharmaceutical companies and policy-makers must take the appropriate steps to ensure that these promising new therapies don’t ultimately lead to the ghettoization of cancer and other genetic diseases.   …”
Get full text

Adverse events in people taking macrolide antibiotics versus placebo for any indication by Hansen, M, Scott, A, McCullough, A, Thorning, S, Aronson, J, Beller, E, Glasziou, P, Hoffmann, T, Clark, J, Mar, D

“…However, differences in resistance thereafter were inconsistent.Pharmaceutical companies supplied the trial medication or funding, or both, for 91 trials.…”

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia by Barber, S, Olotu, U, Corsi, M, Cipriani, A

“…For the first version of the review, we also contacted pharmaceutical companies to identify further trials. Selection criteria We included only RCTs recruiting people of both sexes, aged 18 years or more, with a diagnosis of treatment-resistant schizophrenia (or related disorders) and comparing clozapine plus another antipsychotic drug with clozapine plus a different antipsychotic drug. …”

Desmopressin use for minimising perioperative blood transfusion by Desborough, M, Oakland, K, Brierley, C, Bennett, S, Doree, C, Trivella, M, Hopewell, S, Stanworth, S, Estcourt, L

“…These trials were conducted between 1986 and 2016, and 11 were funded by pharmaceutical companies or by a party with a commercial interest in the outcome of the trial. …”

Interview with Dr. Marcia Angell, former Editor-in-Chief of the New England Journal of Medicine by Michael Reaves

“…Angell’s opinion on a recent decision regarding pharmaceutical companies, Amarin Pharma, Inc. v. United States. …”
Get full text

HEALTH SYSTEM FINANCING IN PAKISTAN: REVIEWING RESOURCES AND OPPORTUNITIES by Fazal Ather, Akhtar Sherin

“…There is corruption in the drug supply as there is a huge influence of pharmaceutical companies in procurements. Poor planning leads to misallocation of resources and there is no concrete health policy which leads to vague outcome in terms of priorities setting. …”
Get full text

Importância da hemoglobina glicada no controle do diabetes mellitus e na avaliação de risco das complicações crônicas Glycohemoglobin importance in the diabetes mellitus control an... by Nairo Massakazu Sumita, Adagmar Andriolo

“…In 2004, the Interdisciplinary Group of Standardization of Glycated Haemoglobin-A1C, a group of specialists from scientific societies and pharmaceutical companies in Brazil, published an official statement about the importance of glycated hemoglobin for the assessment of glycemic control. …”
Get full text

Impacts of Schmallenberg virus infection in early lambing sheep flocks following the second wave of virus circulation in South West England in 2012/2013: a mixed-methods descriptiv... by Michael Glover, Neil Blake, Clare Phythian

“…Application These findings will be of interest to all stakeholders in the sheep industry e.g. farmers, veterinarians, advisers, researchers, welfare organisations, pharmaceutical companies, the UK Government, industry levy boards and other research funding bodies. …”
Get full text

An Advocacy of a Modified Double Standard for Research in Developing Countries by Henry Curtis

“…These treatments are less costly, easier to use, they represent a massive shift in the focus and goals of pharmaceutical companies. However, this trend has also led to a change in how research is conducted. …”
Get full text

The Quest for Ethical Isometric Principles in Cross-Cultural Bioethical Research by Emmanuel Kornyo

“…We also see an increasing trend of pharmaceutical companies relocating their operational outputs and research interests in many emerging/developing countries such as India, South Africa, Ghana, Brazil and Mexico.1 These countries have different and unique socio-linguistic dispositions that are different from those of the researchers. …”
Get full text